US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Entero Therapeutics, Inc.

2.99

0.0000

Volume:- -

Turnover:2.96M

Market Cap:10.05M

PE:-0.17

High:2.99

Open:2.99

Low:2.99

Close:2.99

52wk High:5.84

52wk Low:0.9693

Shares:3.36M

Float Shares:2.02M

Volume Ratio:- -

T/O Rate:- -

Dividend:- -

Dividend Rate:- -

EPS(TTM):-18.0946

EPS(LYR):-15.9831

ROE:-24.28%

ROA:-3.32%

PB:-1.60

PE(LYR):-0.19

Loading ...

Overview Company News Filings

Entero Therapeutics Becomes GridAI Technologies

NASDAQ: ENTO’s Grid AI Strikes Texas Hyperscale Deal as its $50M Industrial Software Platform Enters the AI Race

Grid AI Lands Major AI Data-Center Deal for Entero Therapeutics

Entero Therapeutics Delays Quarterly Financial Report

Entero’s Grid AI Finalizes U.S. Leadership Team for Rapid Data Center Expansion

Grid AI Subsidiary of Entero Therapeutics Integrates LV Grid Team for AI Data Center Expansion

Entero Therapeutics Regains Nasdaq Compliance With Grid AI Acquisition

Entero Therapeutics Secures $5 Million Private Placement with Investor

Entero Therapeutics Transforms With Acquisition of GRID AI, Shifting Focus to AI-Driven Energy Solutions

Entero Therapeutics Completes Acquisition of GRID AI to Expand Into AI-Driven Energy Infrastructure Market

Entero Therapeutics Inc: Acquired 100% of Grid AI Corp

THOMSON REUTERS

Entero Therapeutics Inc: Ento Will File an Initial Listing Application for Its Common Stock

THOMSON REUTERS

Entero Therapeutics Acquires GRID AI to Expand Into High-Growth AI Energy Infrastructure Market

Entero Therapeutics Inc. Appoints Jason D. Sawyer as Interim CEO with New Consulting Agreement

BRIEF-Entero Therapeutics Terminated Interim CEO And Chairman Richard Joel Paolone Effective Immediately - SEC Filing

Entero Therapeutics Inc - on Sept 3 Terminated Interim CEO and Chairman Richard Joel Paolone Effective Immediately - SEC Filing

THOMSON REUTERS

Entero Therapeutics Inc. Appoints Jason D. Sawyer as Interim CEO Following the Termination of Richard Joel Paolone

Entero Therapeutics Inc. Files Initial Beneficial Ownership Statement for Director Jason David Sawyer

Entero Therapeutics Announces 1-for-3 Reverse Stock Split to Maintain Nasdaq Listing

US Stocks Mixed; Owens & Minor Posts Downbeat Earnings

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/ENTO/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"ENTO","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ENTO\",,,,,undefined,":{"symbol":"ENTO","market":"US","secType":"STK","nameCN":"Entero Therapeutics, Inc.","latestPrice":2.99,"timestamp":1764352800000,"preClose":2.99,"halted":8,"volume":0,"delay":0,"changeRate":0,"floatShares":2016200,"shares":3361903,"eps":-18.094645,"marketStatus":"Market Closed","change":0,"latestTime":"11-28 13:00:00 EST","open":2.99,"high":2.99,"low":2.99,"amount":2958897.1187771996,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-18.094645,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1770627600000},"marketStatusCode":7,"symbolChange":{"newSymbol":"GRDX","executeDate":"2025-12-01"},"adr":0,"listingDate":1476158400000,"exchange":"NASDAQ","adjPreClose":2.99,"volumeRatio":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ENTO\",,,,,undefined,":{"symbol":"ENTO","floatShares":2016200,"roa":"-3.32%","roe":"-24.28%","lyrEps":-15.9831,"shares":3361903,"dividePrice":0,"high":2.99,"amplitude":0,"preClose":2.99,"low":2.99,"week52Low":0.9693,"pbRate":"-1.60","week52High":5.84,"institutionHeld":0,"latestPrice":2.99,"eps":-18.094645,"divideRate":0,"volume":0,"delay":0,"ttmEps":-18.094645,"open":2.99},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ENTO\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-12-01","symbol":"ENTO","oldSymbol":"ENTO","defaultRemindTime":1764599400000,"newSymbol":"GRDX","exchange":"NASDAQ","type":"symbolChange","dateTimestamp":1764565200000},{"market":"US","date":"2025-08-18","symbol":"ENTO","defaultRemindTime":1755523800000,"type":"split","dateTimestamp":1755489600000,"forFactor":3,"toFactor":1,"ratio":3},{"market":"US","date":"2025-08-14","symbol":"ENTO","fiscalQuarterEnding":"2025/06","expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1755144000000,"reportTimeType":"","actualEps":-0.14},{"market":"US","date":"2025-05-15","symbol":"ENTO","fiscalQuarterEnding":"2025/03","expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1747281600000,"reportTimeType":"","actualEps":-0.21},{"market":"US","date":"2025-04-01","symbol":"ENTO","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1743480000000,"reportTimeType":"post","actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ENTO\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"ENTO\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/ENTO\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"ENTO","date":"2025-10-30","current":-0.165242,"percent":0.142029,"low":-1.117599,"twenty":-0.367443,"median":-0.224285,"eighty":-0.102892,"high":-0.069878,"avg":-0.267842,"sd":0.210876,"marketCap":7085048},"quantilePoints":[{"date":"2024-05-24","current":-0.927614,"twenty":-0.970244,"median":-0.940771,"eighty":-0.935508,"marketCap":5711061},{"date":"2024-05-31","current":-0.982588,"twenty":-0.972744,"median":-0.960172,"eighty":-0.939455,"marketCap":6049523},{"date":"2024-06-07","current":-1.013075,"twenty":-1.023528,"median":-0.973994,"eighty":-0.952412,"marketCap":6237226},{"date":"2024-06-14","current":-0.884431,"twenty":-1.015488,"median":-0.963958,"eighty":-0.938798,"marketCap":5445198},{"date":"2024-06-21","current":-0.832169,"twenty":-1.006978,"median":-0.960172,"eighty":-0.845837,"marketCap":5123436},{"date":"2024-06-28","current":-0.482417,"twenty":-0.994783,"median":-0.955468,"eighty":-0.832169,"marketCap":2970108},{"date":"2024-07-05","current":-0.399602,"twenty":-0.982337,"median":-0.939126,"eighty":-0.800812,"marketCap":2460239},{"date":"2024-07-12","current":-0.449251,"twenty":-0.981274,"median":-0.884431,"eighty":-0.46312,"marketCap":2765913},{"date":"2024-07-15","current":-0.438195,"twenty":-0.98093,"median":-0.86031,"eighty":-0.449854,"marketCap":2697848},{"date":"2024-08-02","current":-0.249289,"twenty":-0.980587,"median":-0.836189,"eighty":-0.448648,"marketCap":1534805},{"date":"2024-08-09","current":-0.125604,"twenty":-0.970244,"median":-0.832169,"eighty":-0.414396,"marketCap":773307},{"date":"2024-08-16","current":-0.157414,"twenty":-0.961686,"median":-0.779907,"eighty":-0.330047,"marketCap":969155},{"date":"2024-08-23","current":-0.205764,"twenty":-0.960172,"median":-0.486437,"eighty":-0.218699,"marketCap":1266831},{"date":"2024-08-30","current":-0.220374,"twenty":-0.960172,"median":-0.449251,"eighty":-0.21983,"marketCap":1356784},{"date":"2024-09-06","current":-0.213637,"twenty":-0.954527,"median":-0.438195,"eighty":-0.217273,"marketCap":1315305},{"date":"2024-09-13","current":-0.174376,"twenty":-0.944768,"median":-0.408849,"eighty":-0.212728,"marketCap":1073585},{"date":"2024-09-20","current":-0.17966,"twenty":-0.938798,"median":-0.343415,"eighty":-0.190472,"marketCap":1106118},{"date":"2024-09-27","current":-0.183835,"twenty":-0.931561,"median":-0.293586,"eighty":-0.17966,"marketCap":1131819},{"date":"2024-10-04","current":-0.184112,"twenty":-0.901704,"median":-0.232501,"eighty":-0.177546,"marketCap":1133524},{"date":"2024-10-11","current":-0.212422,"twenty":-0.855486,"median":-0.23118,"eighty":-0.17966,"marketCap":1307822},{"date":"2024-10-18","current":-0.384262,"twenty":-0.833777,"median":-0.240216,"eighty":-0.180833,"marketCap":2365792},{"date":"2024-10-25","current":-0.206516,"twenty":-0.832169,"median":-0.235407,"eighty":-0.181837,"marketCap":2225250},{"date":"2024-10-31","current":-0.184113,"twenty":-0.832169,"median":-0.228802,"eighty":-0.181338,"marketCap":1983856},{"date":"2024-11-08","current":-0.19927,"twenty":-0.832169,"median":-0.221933,"eighty":-0.181763,"marketCap":2147171},{"date":"2024-11-15","current":-0.17096,"twenty":-0.811264,"median":-0.221642,"eighty":-0.181763,"marketCap":1696265},{"date":"2024-11-22","current":-0.198843,"twenty":-0.665751,"median":-0.219397,"eighty":-0.17966,"marketCap":1972922},{"date":"2024-11-29","current":-0.226873,"twenty":-0.493706,"median":-0.220374,"eighty":-0.179959,"marketCap":2251033},{"date":"2024-12-06","current":-0.319107,"twenty":-0.488849,"median":-0.221642,"eighty":-0.181246,"marketCap":3166183},{"date":"2024-12-13","current":-0.300277,"twenty":-0.475985,"median":-0.221933,"eighty":-0.181689,"marketCap":2979350},{"date":"2024-12-20","current":-0.2963,"twenty":-0.450055,"median":-0.224285,"eighty":-0.182121,"marketCap":2939892},{"date":"2024-12-27","current":-0.301858,"twenty":-0.449251,"median":-0.226873,"eighty":-0.182664,"marketCap":2995038},{"date":"2025-01-03","current":-0.310483,"twenty":-0.446839,"median":-0.228802,"eighty":-0.183601,"marketCap":3080611},{"date":"2025-01-10","current":-0.297067,"twenty":-0.441411,"median":-0.231244,"eighty":-0.184001,"marketCap":2947498},{"date":"2025-01-17","current":-0.253034,"twenty":-0.433371,"median":-0.238314,"eighty":-0.184113,"marketCap":2510603},{"date":"2025-01-24","current":-0.240049,"twenty":-0.425331,"median":-0.240216,"eighty":-0.184234,"marketCap":2381769},{"date":"2025-01-31","current":-0.239522,"twenty":-0.410698,"median":-0.23981,"eighty":-0.18505,"marketCap":2376539},{"date":"2025-02-07","current":-0.241966,"twenty":-0.399602,"median":-0.240216,"eighty":-0.186061,"marketCap":2400785},{"date":"2025-02-14","current":-0.241966,"twenty":-0.396044,"median":-0.240133,"eighty":-0.186568,"marketCap":2400785},{"date":"2025-02-21","current":-0.248338,"twenty":-0.389419,"median":-0.241091,"eighty":-0.187797,"marketCap":2464013},{"date":"2025-02-28","current":-0.227256,"twenty":-0.384072,"median":-0.240001,"eighty":-0.19026,"marketCap":2254836},{"date":"2025-03-07","current":-0.268318,"twenty":-0.383235,"median":-0.240133,"eighty":-0.190804,"marketCap":2662256},{"date":"2025-03-14","current":-0.226154,"twenty":-0.375026,"median":-0.240001,"eighty":-0.192454,"marketCap":2243902},{"date":"2025-03-21","current":-0.245367,"twenty":-0.340784,"median":-0.240133,"eighty":-0.19453,"marketCap":2434538},{"date":"2025-03-28","current":-0.25634,"twenty":-0.330047,"median":-0.241966,"eighty":-0.198928,"marketCap":2543406},{"date":"2025-04-04","current":-0.115038,"twenty":-0.328524,"median":-0.240133,"eighty":-0.192454,"marketCap":2077511},{"date":"2025-04-11","current":-0.106349,"twenty":-0.324473,"median":-0.239618,"eighty":-0.186359,"marketCap":1920588},{"date":"2025-04-17","current":-0.100543,"twenty":-0.319107,"median":-0.23957,"eighty":-0.184113,"marketCap":1815742},{"date":"2025-04-25","current":-0.099356,"twenty":-0.316889,"median":-0.239546,"eighty":-0.181985,"marketCap":1794296},{"date":"2025-05-02","current":-0.093629,"twenty":-0.314316,"median":-0.238755,"eighty":-0.17966,"marketCap":1690880},{"date":"2025-05-09","current":-0.105214,"twenty":-0.312399,"median":-0.237341,"eighty":-0.172579,"marketCap":1900096},{"date":"2025-05-16","current":-0.113474,"twenty":-0.310483,"median":-0.235737,"eighty":-0.169092,"marketCap":2049263},{"date":"2025-05-23","current":-0.079663,"twenty":-0.303152,"median":-0.230706,"eighty":-0.15958,"marketCap":1982543},{"date":"2025-05-30","current":-0.078897,"twenty":-0.303152,"median":-0.230107,"eighty":-0.152669,"marketCap":1963480},{"date":"2025-06-06","current":-0.094217,"twenty":-0.302117,"median":-0.229987,"eighty":-0.133949,"marketCap":2344738},{"date":"2025-06-13","current":-0.105515,"twenty":-0.301858,"median":-0.228148,"eighty":-0.125604,"marketCap":2625916},{"date":"2025-06-20","current":-0.092743,"twenty":-0.300909,"median":-0.227424,"eighty":-0.114234,"marketCap":2308042},{"date":"2025-06-27","current":-0.083302,"twenty":-0.298926,"median":-0.226873,"eighty":-0.110666,"marketCap":2073092},{"date":"2025-07-03","current":-0.077135,"twenty":-0.297642,"median":-0.226154,"eighty":-0.108624,"marketCap":1919635},{"date":"2025-07-11","current":-0.09326,"twenty":-0.297067,"median":-0.222444,"eighty":-0.10589,"marketCap":2320910},{"date":"2025-07-18","current":-0.090617,"twenty":-0.297067,"median":-0.221933,"eighty":-0.10496,"marketCap":2255142},{"date":"2025-07-25","current":-0.092704,"twenty":-0.29676,"median":-0.220905,"eighty":-0.101582,"marketCap":2307089},{"date":"2025-08-01","current":-0.084259,"twenty":-0.296113,"median":-0.219397,"eighty":-0.099669,"marketCap":2096920},{"date":"2025-08-08","current":-0.074493,"twenty":-0.294409,"median":-0.217423,"eighty":-0.095918,"marketCap":1853868},{"date":"2025-08-15","current":-0.117446,"twenty":-0.291509,"median":-0.215272,"eighty":-0.095918,"marketCap":2922821},{"date":"2025-08-22","current":-0.188838,"twenty":-0.289401,"median":-0.211894,"eighty":-0.096521,"marketCap":3224809},{"date":"2025-08-29","current":-0.200001,"twenty":-0.287465,"median":-0.207724,"eighty":-0.098073,"marketCap":3415438},{"date":"2025-09-05","current":-0.246512,"twenty":-0.285903,"median":-0.211365,"eighty":-0.099401,"marketCap":4209726},{"date":"2025-09-12","current":-0.213954,"twenty":-0.282463,"median":-0.213029,"eighty":-0.099624,"marketCap":3653724},{"date":"2025-09-19","current":-0.427908,"twenty":-0.291892,"median":-0.215272,"eighty":-0.099846,"marketCap":7307449},{"date":"2025-09-26","current":-0.438141,"twenty":-0.296914,"median":-0.216948,"eighty":-0.100121,"marketCap":7482192},{"date":"2025-10-03","current":-0.403722,"twenty":-0.299827,"median":-0.218657,"eighty":-0.100737,"marketCap":6894419},{"date":"2025-10-10","current":-0.43349,"twenty":-0.303152,"median":-0.220389,"eighty":-0.101547,"marketCap":7402764},{"date":"2025-10-17","current":-0.454885,"twenty":-0.316374,"median":-0.22188,"eighty":-0.101846,"marketCap":7768136},{"date":"2025-10-24","current":-0.405583,"twenty":-0.330047,"median":-0.221962,"eighty":-0.10257,"marketCap":6926191},{"date":"2025-10-30","current":-0.414885,"twenty":-0.367443,"median":-0.224285,"eighty":-0.102892,"marketCap":7085048}],"updateTime":1770548408512},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"ENTO\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2586782790","title":"Entero Therapeutics Becomes GridAI Technologies","url":"https://stock-news.laohu8.com/highlight/detail?id=2586782790","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586782790?lang=en_us&edition=fundamental","pubTime":"2025-11-28 21:00","pubTimestamp":1764334824,"startTime":"0","endTime":"0","summary":"Entero Therapeutics Inc. has announced a corporate name change to GridAI Technologies Corp. and will adopt the new ticker symbol \"GRDX\" following its acquisition of GRID AI Corp.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Entero Therapeutics Inc. published the original content used to generate this news brief via ACCESS Newswire  on November 28, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251128:nNDL7dZN2L:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ENTO","GRDX","BK4139"],"gpt_icon":0},{"id":"2584269942","title":"NASDAQ: ENTO’s Grid AI Strikes Texas Hyperscale Deal as its $50M Industrial Software Platform Enters the AI Race","url":"https://stock-news.laohu8.com/highlight/detail?id=2584269942","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584269942?lang=en_us&edition=fundamental","pubTime":"2025-11-19 22:00","pubTimestamp":1763560800,"startTime":"0","endTime":"0","summary":"Artificial intelligence has ignited the most aggressive physical-infrastructure buildout in modern history. Behind the headlines about trillion-par...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/nasdaq-entos-grid-ai-strikes-texas-hyperscale-deal-as-its-50m-industrial-software-platform-enters-the-ai-race?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/nasdaq-entos-grid-ai-strikes-texas-hyperscale-deal-as-its-50m-industrial-software-platform-enters-the-ai-race?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ENTO","TSYW.SI","USJW.SI","BK4139",".IXIC","SQQQ","TQQQ","MNQmain","NQmain","QID","QLD","USAW.SI","PSQ","NVIW.SI"],"gpt_icon":0},{"id":"2584944188","title":"Grid AI Lands Major AI Data-Center Deal for Entero Therapeutics","url":"https://stock-news.laohu8.com/highlight/detail?id=2584944188","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584944188?lang=en_us&edition=fundamental","pubTime":"2025-11-19 21:45","pubTimestamp":1763559913,"startTime":"0","endTime":"0","summary":"Entero Therapeutics Inc. announced that its subsidiary, Grid AI, has signed a Letter of Intent with a stealth-mode hyperscaler AI data-center developer. Grid AI will deploy its advanced power-cluster optimization and orchestration platform at the customer's first large-scale AI campus in Texas, with plans for additional campuses globally.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Entero Therapeutics Inc. published the original content used to generate this news brief via ACCESS Newswire  on November 19, 2025, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251119:nNDL6NPW2z:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ENTO","BK4139"],"gpt_icon":0},{"id":"2584667128","title":"Entero Therapeutics Delays Quarterly Financial Report","url":"https://stock-news.laohu8.com/highlight/detail?id=2584667128","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584667128?lang=en_us&edition=fundamental","pubTime":"2025-11-18 05:01","pubTimestamp":1763413316,"startTime":"0","endTime":"0","summary":"Entero Therapeutics Inc. has announced a delay in filing its quarterly report on Form 10-Q for the financial period ended September 30, 2025. The company cited that the reasons for the delay could not be eliminated without unreasonable effort or expense and expects to file the report within the permitted extension period.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Entero Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on November 17, 2025, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251117:nNDL93sfDl:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ENTO","BK4139"],"gpt_icon":0},{"id":"2583691593","title":"Entero’s Grid AI Finalizes U.S. Leadership Team for Rapid Data Center Expansion","url":"https://stock-news.laohu8.com/highlight/detail?id=2583691593","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583691593?lang=en_us&edition=fundamental","pubTime":"2025-11-13 21:35","pubTimestamp":1763040921,"startTime":"0","endTime":"0","summary":"Entero Therapeutics Inc. announced that its wholly owned subsidiary, Grid AI, is finalizing the establishment of a U.S.-based leadership team to accelerate its expansion into the U.S. market for AI-ready digital infrastructure and orchestration technology. Grid AI's new executive team will focus on integrating AI orchestration, energy optimization, and digital infrastructure controls for major AI deployments.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Entero Therapeutics Inc. published the original content used to generate this news brief via ACCESS Newswire  on November 13, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251113:nNDL9GQbkY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ENTO"],"gpt_icon":0},{"id":"2581096764","title":"Grid AI Subsidiary of Entero Therapeutics Integrates LV Grid Team for AI Data Center Expansion","url":"https://stock-news.laohu8.com/highlight/detail?id=2581096764","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581096764?lang=en_us&edition=fundamental","pubTime":"2025-11-06 21:45","pubTimestamp":1762436726,"startTime":"0","endTime":"0","summary":"Entero Therapeutics Inc. announced the integration of the LV Grid engineering team and intellectual property into its subsidiary, Grid AI. The move strengthens Grid AI's position in the AI data-center energy-orchestration market, with LV Grid's team set to lead development of Grid AI's AI Data Center Controls division.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Entero Therapeutics Inc. published the original content used to generate this news brief via ACCESS Newswire  on November 06, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251106:nNDL6H7qh6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ENTO","BK4139"],"gpt_icon":0},{"id":"2579116867","title":"Entero Therapeutics Regains Nasdaq Compliance With Grid AI Acquisition","url":"https://stock-news.laohu8.com/highlight/detail?id=2579116867","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2579116867?lang=en_us&edition=fundamental","pubTime":"2025-10-30 18:00","pubTimestamp":1761818434,"startTime":"0","endTime":"0","summary":"Entero Therapeutics Inc. has completed the acquisition of 100% of Grid AI Corp., making Grid AI a wholly-owned subsidiary. With this move, Entero now operates at the intersection of AI, data centers, power grids, and global infrastructure. The acquisition positions the company to participate in the rapidly growing sectors of hyperscale data centers, grid-edge orchestration, and AI-driven infrastructure optimization. According to Entero, this transaction has also enabled the company to regain compliance with Nasdaq's equity requirements.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Entero Therapeutics Inc. published the original content used to generate this news brief via ACCESS Newswire  on October 30, 2025, and is solely responsibl","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251030:nNDL1Y62L4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ENTO","BK4139"],"gpt_icon":0},{"id":"2577315426","title":"Entero Therapeutics Secures $5 Million Private Placement with Investor","url":"https://stock-news.laohu8.com/highlight/detail?id=2577315426","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2577315426?lang=en_us&edition=fundamental","pubTime":"2025-10-23 04:02","pubTimestamp":1761163353,"startTime":"0","endTime":"0","summary":"Entero Therapeutics Inc. has entered into a securities purchase agreement with an investor for a private placement of up to $5 million in promissory notes and warrants to purchase up to 1,520,000 shares of common stock. The company completed an initial closing on October 17, 2025, raising $500,000 through the sale of a promissory note and a warrant to purchase 200,000 shares. Proceeds will be used for general corporate purposes, including working capital and potential acquisitions.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Entero Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Comm","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251022:nNDL8hQTM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ENTO","BK4139"],"gpt_icon":0},{"id":"2575229779","title":"Entero Therapeutics Transforms With Acquisition of GRID AI, Shifting Focus to AI-Driven Energy Solutions","url":"https://stock-news.laohu8.com/highlight/detail?id=2575229779","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2575229779?lang=en_us&edition=fundamental","pubTime":"2025-10-14 20:05","pubTimestamp":1760443555,"startTime":"0","endTime":"0","summary":"Entero Therapeutics Inc. has completed a major transformation by acquiring GRID AI, shifting its focus from biotechnology to the grid-edge energy technology sector. As a result of the deal, GRID AI shareholders now hold more than 80 percent of Entero's equity on a fully diluted basis and have significant influence on the company's board. This acquisition positions Entero as a public gateway for AI-driven energy solutions at a time when demand for grid resilience is growing rapidly. The company now operates with a streamlined share float of 1.69 million fully diluted shares, enhancing its visibility and responsiveness in the market. The transition marks Entero's move from lengthy biotech development cycles to addressing immediate challenges in energy technology.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251014:nNDL9lCK68:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ENTO","BK4139"],"gpt_icon":0},{"id":"2573398323","title":"Entero Therapeutics Completes Acquisition of GRID AI to Expand Into AI-Driven Energy Infrastructure Market","url":"https://stock-news.laohu8.com/highlight/detail?id=2573398323","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2573398323?lang=en_us&edition=fundamental","pubTime":"2025-10-07 04:39","pubTimestamp":1759783193,"startTime":"0","endTime":"0","summary":"Entero Therapeutics Inc.  has completed the acquisition of 100% of GRID AI Corp, a company specializing in grid-edge, AI-driven software and device platforms for managing dynamic power loads and distributed energy resources. As part of the agreement, former GRID AI shareholders will hold approximately 82.5% of ENTO's fully diluted common stock, with the ability to appoint a majority of the board of directors upon full implementation. The transaction is expected to position ENTO in the rapidly growing AI energy-infrastructure market, as demand for data centers and behind-the-meter energy storage solutions accelerates. Over $50 million has been invested since 2019 to commercialize GRID AI's platform, which leverages AI, machine learning, and edge analytics to balance supply and demand across millions of assets, enhancing grid reliability and resilience.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251006:nNDL8H0yVS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ENTO"],"gpt_icon":0},{"id":"2572557877","title":"Entero Therapeutics Inc: Acquired 100% of Grid AI Corp","url":"https://stock-news.laohu8.com/highlight/detail?id=2572557877","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2572557877?lang=en_us&edition=fundamental","pubTime":"2025-10-02 04:13","pubTimestamp":1759349623,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251001:nFWN3VI1BE:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ENTO","BK4139"],"gpt_icon":0},{"id":"2572355738","title":"Entero Therapeutics Inc: Ento Will File an Initial Listing Application for Its Common Stock","url":"https://stock-news.laohu8.com/highlight/detail?id=2572355738","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2572355738?lang=en_us&edition=fundamental","pubTime":"2025-10-02 04:13","pubTimestamp":1759349623,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251001:nFWN3VI1BE:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ENTO","BK4139"],"gpt_icon":0},{"id":"2572539734","title":"Entero Therapeutics Acquires GRID AI to Expand Into High-Growth AI Energy Infrastructure Market","url":"https://stock-news.laohu8.com/highlight/detail?id=2572539734","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2572539734?lang=en_us&edition=fundamental","pubTime":"2025-10-01 20:31","pubTimestamp":1759321862,"startTime":"0","endTime":"0","summary":"Entero Therapeutics Inc.  announced that it has acquired 100% of GRID AI Corp, a grid-edge, AI-driven software and device platform designed to help utilities, retailers, and large power users dynamically manage load and distributed energy resources. Following the completion of the transaction, former shareholders of GRID AI will own approximately 82.5% of ENTO's fully diluted common stock, while existing ENTO shareholders will retain around 17.5%. As part of the agreement, former GRID AI shareholders will designate two directors to ENTO's board, with the right to appoint additional directors upon full implementation, ultimately holding five of seven board seats. ENTO stated that the acquisition will expand its reach into the high-growth AI energy-infrastructure market and diversify its portfolio into critical infrastructure software, including energy flexibility and virtual power plants.Disclaimer: This news brief was created by Public Technologies  using generative artificial intellig","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251001:nNDL8v0144:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ENTO"],"gpt_icon":0},{"id":"2567904850","title":"Entero Therapeutics Inc. Appoints Jason D. Sawyer as Interim CEO with New Consulting Agreement","url":"https://stock-news.laohu8.com/highlight/detail?id=2567904850","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2567904850?lang=en_us&edition=fundamental","pubTime":"2025-09-13 04:31","pubTimestamp":1757709103,"startTime":"0","endTime":"0","summary":"Entero Therapeutics Inc. has appointed Jason D. Sawyer as the Interim Chief Executive Officer, effective September 4, 2025. The company formalized this appointment through a consulting agreement signed on September 8, 2025.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Entero Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on September 12, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250912:nNDL5zjvWM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ENTO","BK4139"],"gpt_icon":0},{"id":"2566451346","title":"BRIEF-Entero Therapeutics Terminated Interim CEO And Chairman Richard Joel Paolone Effective Immediately  - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2566451346","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2566451346?lang=en_us&edition=fundamental","pubTime":"2025-09-10 05:05","pubTimestamp":1757451932,"startTime":"0","endTime":"0","summary":"BRIEF-Entero Therapeutics Terminated Interim CEO And Chairman Richard Joel Paolone Effective Immediately  - SEC FilingSept 9  - Entero Therapeutics Inc ENTO.O:ENTERO THERAPEUTICS INC - ON SEPT 3 TERMINATED INTERIM CEO AND CHAIRMAN RICHARD JOEL PAOLONE EFFECTIVE IMMEDIATELY  - SEC FILINGENTERO THERAPEUTICS INC - ON SPET 4 APPOINTED JASON D. SAWYER AS INTERIM CEO - SEC FILINGENTERO THERAPEUTICS INC - PAOLONE REMAINS DIRECTOR AFTER TERMINATION AS CEO - SEC FILINGSource text: [ID:n0001104659-25-088663]Further company coverage: ENTO.O ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250909:nFWN3UW0DE:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ENTO"],"gpt_icon":0},{"id":"2566645984","title":"Entero Therapeutics Inc - on Sept 3 Terminated Interim CEO and Chairman Richard Joel Paolone Effective Immediately  - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2566645984","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2566645984?lang=en_us&edition=fundamental","pubTime":"2025-09-10 05:02","pubTimestamp":1757451747,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250909:nFWN3UW0DE:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","ENTO"],"gpt_icon":0},{"id":"2566645972","title":"Entero Therapeutics Inc. Appoints Jason D. Sawyer as Interim CEO Following the Termination of Richard Joel Paolone","url":"https://stock-news.laohu8.com/highlight/detail?id=2566645972","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2566645972?lang=en_us&edition=fundamental","pubTime":"2025-09-10 05:00","pubTimestamp":1757451616,"startTime":"0","endTime":"0","summary":"Entero Therapeutics Inc. announced a management change on September 3, 2025, with the termination of Richard Joel Paolone as Interim Chief Executive Officer and Chairman of the Board. Jason D. Sawyer has been appointed as the new Interim Chief Executive Officer, effective September 4, 2025. Sawyer, who will continue to serve as a director on the company's board, brings extensive experience from the alternative investment industry, including roles at Access Alternative Group S.A. and previous positions at Crane Capital Associates and Candlebrook Capital.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Entero Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysi","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250909:nNDL9v3vrJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ENTO"],"gpt_icon":0},{"id":"2560833131","title":"Entero Therapeutics Inc. Files Initial Beneficial Ownership Statement for Director Jason David Sawyer","url":"https://stock-news.laohu8.com/highlight/detail?id=2560833131","media":"Reuters","labels":["executive","shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2560833131?lang=en_us&edition=fundamental","pubTime":"2025-08-19 06:57","pubTimestamp":1755557826,"startTime":"0","endTime":"0","summary":"Entero Therapeutics Inc. has filed an initial statement of beneficial ownership with the United States Securities and Exchange Commission. The filing identifies Jason David Sawyer as a director of the company. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Entero Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on August 18, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250818:nNDL82gTss:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive,shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ENTO"],"gpt_icon":0},{"id":"2559957007","title":"Entero Therapeutics Announces 1-for-3 Reverse Stock Split to Maintain Nasdaq Listing","url":"https://stock-news.laohu8.com/highlight/detail?id=2559957007","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2559957007?lang=en_us&edition=fundamental","pubTime":"2025-08-14 21:16","pubTimestamp":1755177367,"startTime":"0","endTime":"0","summary":"Entero Therapeutics Inc., a clinical-stage biopharmaceutical company, announced a 1 for 3 reverse stock split of its common stock, effective August 18, 2025. This move aims to comply with Nasdaq's minimum bid price requirement for continued listing. The split will reduce the company's outstanding shares from approximately 4.77 million to 1.59 million.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Entero Therapeutics Inc. published the original content used to generate this news brief via Newsfile  on August 14, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250814:nNDLcfXjfD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4112","IE00B3QW5Z07.USD","LU2210149790.SGD","IE00B64PRP62.GBP","IE00BGHQF748.EUR","LU0314104364.USD","BK4588","NDAQ","LU2095319765.USD","IE00BKPKM429.USD","ENTO","BK4585","BK4139","LU2210150020.SGD"],"gpt_icon":0},{"id":"2558665234","title":"US Stocks Mixed; Owens & Minor Posts Downbeat Earnings","url":"https://stock-news.laohu8.com/highlight/detail?id=2558665234","media":"Benzinga","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2558665234?lang=en_us&edition=fundamental","pubTime":"2025-08-11 21:50","pubTimestamp":1754920223,"startTime":"0","endTime":"0","summary":" ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/markets/market-summary/25/08/47031060/us-stocks-mixed-owens-minor-posts-downbeat-earnings","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ENTO","EQ","IMXI","SHOT","OMI","TZUP","VSEE"],"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":1,"totalSize":25,"code":"91000000","status":"200"}]}}